Testing effectiveness (Phase 2)Active Not RecruitingNCT02592083
What this trial is testing
Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors
Who this might be right for
Early-Stage Breast CarcinomaHormone Receptor Positive Tumor
Thomas Hatschek 10